Sanofi announces upcoming launch of MyStar Connect
MyStar Connect software contributes to Sanofi’s commitment in providing integrated diabetes care solutions and supports healthcare professionals in clinical decision-making
Sanofi has announced the upcoming launch of MyStar Connect, an easy-to-use, comprehensive diabetes data management software platform for healthcare professionals (HCPs).
MyStar Connect will support HCPs in the delivery of individualised patient care by providing necessary insights and analysis to optimise diabetes management. The new software is part of the MyStar portfolio consisting of medical devices, support services and guidance and connects to Sanofi’s BGStar and MyStar Extra blood glucose meters.
The upcoming launch of MyStar Connect is another step forward in Sanofi’s long-term commitment to improving diabetes care
“At Sanofi, our integrated care strategy, rather than just developing drugs alone, aims to support people with diabetes holistically, improving patient experiences and outcomes,” said Pierre Chancel, senior vice president for global diabetes at Sanofi.
“The upcoming launch of MyStar Connect is another step forward in Sanofi’s long-term commitment to improving diabetes care, helping to streamline and simplify the way HCPs can access and visualise their patients’ blood glucose data.”
Research has shown that too much information can cause confusion, whereas integrating and simplifying data management has the opposite effect. MyStar Connect automates data collection from Sanofi’s BGStar and MyStar Extra blood glucose meters, and safely stores all patients data in between visits.
MyStar Connect’s comprehensive and intuitive dashboard enables HCPs to set personal targets for each patient and to quickly review their key metrics, targets and trends. By making use of colour coding to indicate personal target achievements and trend arrows that summarise changes over time, MyStar Connect helps HCPs to easily identify trends and key areas needing attention and thus supports their clinical decision-making for each individual patient.
Successful diabetes management requires a high level of patient involvement in self-monitoring and care. With MyStar Connect, HCPs will be able to help people with diabetes to improve their understanding of the disease and therapy progress by sharing and discussing with them easy-to-read reports.
Our integrated care strategy, rather than just developing drugs alone, aims to support people with diabetes holistically, improving patient experiences and outcomes
The CE mark for MyStar Connect was obtained by Meteda, the developer of the software in partnership with Sanofi.
Now approved in Europe, MyStar Connect will be available in selected European countries at the beginning of 2015 and will complement the MyStar portfolio of Sanofi, combining devices, services and guidance for simple and effective diabetes management.